Manitex Capital Inc. announced that it has appointed Dr. Ed Margerrison as President and CEO. Dr. Margerrison is an industry veteran with 25 years experience in the orthopedic industry. A Ph.D in molecular biology, Dr. Margerrison most recently led the biologics division of Zimmer Inc. Prior to this, Dr. Margerrison had spent 14 years at Smith & Nephew Orthopedics.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.31 CAD | +24.00% | 0.00% | +34.78% |
29/03 | Manitex Capital Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
28/02 | Manitex Capital Inc. Reports Earnings Results for the Full Year Ended October 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+34.78% | 28.55L | |
+50.70% | 79TCr | |
+41.96% | 63TCr | |
-7.15% | 35TCr | |
+18.77% | 33TCr | |
+8.79% | 30TCr | |
+18.02% | 25TCr | |
+1.27% | 22TCr | |
+11.95% | 22TCr | |
+3.68% | 16TCr |
- Stock Market
- Equities
- MNX Stock
- News Manitex Capital Inc.
- Manitex Capital Inc. Appoints Ed Margerrison as President and CEO